Concepedia

Publication | Closed Access

Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial

DOI

130

Citations

31

References

2014

Year

Meisam Sanoobar, Shahryar Eghtesadi, Amirreza Azimi, Mohammad Khalili, Behnam Khodadadi, Shima Jazayeri, Mahmood Reza Gohari
Nutritional Neuroscience

Abstract

CoQ10 supplementation at a dosage of 500 mg appears to decrease the inflammatory markers (TNF-α, IL-6, and MMP-9) in patients with MS.

References

YearCitations

Page 1